PUBLISHER: The Business Research Company | PRODUCT CODE: 1455247
PUBLISHER: The Business Research Company | PRODUCT CODE: 1455247
Hemodialysis chairs are specialized pieces of medical furniture crafted to offer comfort and support to individuals undergoing hemodialysis treatment. Hemodialysis is a medical process employed to eliminate waste products and excess fluids from the blood when the kidneys are incapable of performing this function adequately. The significance of hemodialysis chairs lies in their pivotal role in ensuring that patients can engage in activities, maintain mobility, and have easy accessibility.
The primary classifications of hemodialysis chairs encompass manual hemodialysis chairs and electrical hemodialysis chairs. A manual hemodialysis chair is a specially designed medical chair tailored for use in hemodialysis procedures. These chairs are constructed using various materials, including leather, vinyl, and others. They find application across diverse end-users such as hospitals, hemodialysis research centers, government organizations, ambulatory centers, and home care.
The hemodialysis chairs market research report is one of a series of new reports from The Business Research Company that provides hemodialysis chairs market statistics, including hemodialysis chairs industry global market size, regional shares, competitors with a hemodialysis chairs market share, detailed hemodialysis chairs market segments, market trends, and opportunities, and any further data you may need to thrive in the hemodialysis chairs industry. This hemodialysis chairs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hemodialysis chairs market size has grown strongly in recent years. It will grow from $80.6 billion in 2023 to $85.91 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth observed in the historical period can be ascribed to the escalating incidence of hernias, an increase in obesity rates, an aging population, a preference among patients for less invasive surgeries, the evolving regulatory environment, and collaborations between surgeons and manufacturers.
The hemodialysis chairs market size is expected to see strong growth in the next few years. It will grow to $105.87 billion in 2028 at a compound annual growth rate (CAGR) of 5.4%. The anticipated growth in the forecast period can be credited to a focus on biocompatible materials, personalized treatment approaches, global health initiatives, increased education for both patients and physicians, and a rising demand for robotic-assisted surgery. Major trends expected in the forecast period involve advancements in biocompatible materials, emphasis on minimally invasive techniques, innovation in absorbable mesh technology, customization for complex hernias, and the integration of barrier coatings.
The growth of the hemodialysis chair market is anticipated to be driven by the increasing prevalence of kidney diseases. Renal diseases, which affect the structure and function of the kidneys, have led to a rising demand for hemodialysis chairs. These chairs play a crucial role in assisting kidney patients during prolonged dialysis sessions by providing comfort, safety, cushioning, and monitoring capabilities. In February 2023, the Australian Institute of Health and Welfare reported a growth in hospitalizations with chronic kidney disease as the primary diagnosis, excluding dialysis, from 197 to 205 per 100,000 people between 2020 and 2021. Additionally, the number of individuals undergoing kidney replacement therapy increased from 94 in 2019 to 95 in 2021 per 100,000 people. The surge in kidney diseases is a key factor fueling the expansion of the hemodialysis chair market.
The increasing incidence of diabetes is contributing to the growth of the hemodialysis chairs market. Diabetes, characterized by elevated blood glucose levels, necessitates hemodialysis therapy for many individuals to manage the condition. This heightened demand for hemodialysis chairs is exemplified by the statistics from April 2023 provided by Diabetes UK, a UK-based healthcare professional organization. The UK witnessed a significant rise in diabetes cases, reaching 4.3 million diagnosed cases, with a yearly increase of 148,951, and over 2.4 million individuals at high risk of type 2 diabetes. Of these cases, approximately 90% are type 2, 8% are type 1, and 2% belong to other forms, with an estimated 850,000 remaining undiagnosed. This surge in diabetes cases is a key driver behind the growth of the hemodialysis chairs market.
The hemodialysis chair market has experienced adverse effects due to the Russia-Ukraine war, leading to disruptions in the healthcare supply chain. These disruptions extend beyond critical medical devices to ancillary products such as hemodialysis chairs, crucial for patient comfort and care. The interconnected nature of healthcare supply chains becomes evident, emphasizing the need to address bottlenecks to ensure comprehensive patient care. According to the National Library of Medicine in December 2022 and Medscape in April 2023, the war has caused supply chain breaks, potentially impacting the availability of medical equipment, including hemodialysis chairs. Consequently, the growth of the hemodialysis chairs market is hindered by the ongoing Russia-Ukraine conflict.
Key players in the hemodialysis chairs market are concentrating on the development of innovative electric linear actuators with IO-link for enhanced customer service. Electric linear actuators, motor-driven linear drives used in positioning and handling systems, play a crucial role in hospital treatment dialysis chairs to enhance movement, comfort, and safety. Linak U.S. Inc., a machinery manufacturing company based in the US, introduced the first electric linear actuator with IO-link in January 2021. This actuator's integration into an IO-Link network and replacement is straightforward due to its all-inclusive electronics. The use of IO-Link streamlines installation, configuration, and diagnostics, aligning with the communication interfaces employed in modern factories.
In June 2023, AngioDynamics Inc., a US-based medical device company, acquired Merit Medical Systems Inc. for $132.5 million. This acquisition aims to bolster AngioDynamics' position in the dialysis and biopsy market, expanding its range of specialist dialysis devices, including the surfacer system, HeRO graft, and Wrapsody cell-impermeable endoprosthesis. Merit Medical Systems Inc., a US-based company specializing in manufacturing hemodialysis chairs, becomes part of this effort to reinforce AngioDynamics' presence in the market.
Major companies operating in the hemodialysis chairs market report are Greiner Bio-One, Rockwell Medical Inc., Honeywell International Inc., Medtronic PLC, Asahi Kasei Medical Co. Ltd., Kimberly-Clark Corporation, Toray Medical Co. Ltd., DaVita Healthcare Partners Inc., Nipro Corporation, Ahlstrom Munksjo Oy, Getinge Group, Nikkiso Co. Ltd., Belimed AG, NxStage Medical Inc., Champion Manufacturing Inc., Digiterm Ltd., Euroclinic SpA, Seers Medical Ltd., Acime-Frame, Health Tec Medical Ltd., Medi-Plinth Equipment Ltd., Actualway Holdings Ltd., Matachana Group, Diasol Inc., Synergy Health PLC, Fresenius SE & Co KGaA, Acime-Frame, Sakura Global Holding Company Ltd., Cisa S.p.A, Medivators Inc.
Asia Pacific was the largest region in the hemodialysis chairs market in 2023. The regions covered in the hemodialysis chairs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the hemodialysis chair market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The hemodialysis chair market consists of sales of power-assisted hemodialysis chairs, and customizable hemodialysis chairs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Hemodialysis Chairs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on hemodialysis chairs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for hemodialysis chairs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hemodialysis chairs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of covid 19 on supply chains and consumption patterns.